New injection tested to tame stubborn genetic cholesterol
NCT ID NCT07450378
Summary
This study is testing if a new injectable drug called QLC7401 can further lower 'bad' cholesterol in adults with an inherited form of high cholesterol. Participants, who are already on stable cholesterol medication, will receive either the new drug or a placebo injection. The main goal is to see how much it reduces LDL cholesterol and to check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.